Product Images Redpharm Drug
View Photos of Packaging, Labels & Appearance
- b5387e98-figure-01 - b5387e98 figure 01
- b5387e98-figure-02 - b5387e98 figure 02
- b5387e98-figure-03 - b5387e98 figure 03
- b5387e98-figure-04 - b5387e98 figure 04
- b5387e98-figure-05 - b5387e98 figure 05
- b5387e98-figure-06 - b5387e98 figure 06
- b5387e98-figure-07 - b5387e98 figure 07
- b5387e98-figure-08 - b5387e98 figure 08
- Figure 09 - b5387e98 figure 09
- Figure 10 - b5387e98 figure 10
- Figure 11 - b5387e98 figure 11
- Figure 12 - b5387e98 figure 12
- Figure 13 - b5387e98 figure 13
- Figure 14 - b5387e98 figure 14
Product Label Images
The following 14 images provide visual information about the product associated with Redpharm Drug NDC 67296-0769 by Redpharm Drug, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
b5387e98-figure-01 - b5387e98 figure 01
b5387e98-figure-02 - b5387e98 figure 02
b5387e98-figure-03 - b5387e98 figure 03
This text appears to be a description of a pharmaceutical product. It mentions "Albuterol" and "Ipratropium" mixed in an inhalation solution, possibly used for the treatment of respiratory conditions such as asthma or chronic obstructive pulmonary disease.*
b5387e98-figure-04 - b5387e98 figure 04
This text provides information on adverse events occurring in different treatment groups and the highest percentage of those occurrences. The data includes the number of patients, percentage of patients with adverse events, and specific adverse events related to different body systems such as BODY AS AWHOLE, DIGESTIVE, MUSCULO-SKELETAL, RESPIRATORY, and UROGENITAL. Some of the adverse events mentioned are pain, pain chest, diarrhea, dyspepsia, nausea, cramps leg, bronchitis, lung disease, pharyngitis, pneumonia, and urinary tract infection. This information can be used for medical evaluation and monitoring of treatments.*
b5387e98-figure-05 - b5387e98 figure 05
b5387e98-figure-06 - b5387e98 figure 06
b5387e98-figure-07 - b5387e98 figure 07
b5387e98-figure-08 - b5387e98 figure 08
Figure 09 - b5387e98 figure 09
This is a description of a medication containing Ipratropium Bromide and Albuterol Sulfate for oral inhalation. Each vial contains 0.5 mg of Ipratropium Bromide and 3 mg of Albuterol Sulfate. It should be stored between 2°C and 25°C, protected from light, in the provided pouch until use. The vials should be used within one week of opening and discarded if the solution is not colorless. It is important to follow the prescribing information and consult a physician or pharmacist for further details. This medication is available as a 5 x 3 mL unit-dose vials.*
Figure 10 - b5387e98 figure 10
This text provides information about a medication with National Drug Code (NDC) 0467-0201-03 containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg for oral inhalation use. The text also mentions another NDC code 0487-0201-03 for the same medication. It is indicated for respiratory conditions.*
Figure 11 - b5387e98 figure 11
This is a prescription for an oral inhalation medication containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg. The medication is meant for oral inhalation only. The label also contains the product codes NDC 0487020150 and NDC 0487-020150. Please consult a healthcare professional before using this medication.*
Figure 12 - b5387e98 figure 12
This text provides detailed patient instructions for using Ipratropium Bromide and Albuterol Sulfate for oral inhalation. It includes steps on how to properly use the medication with a nebulizer for effective administration. The text also mentions storage conditions, dosage information, and emphasizes that the medication should only be used under the direction of a physician. Additionally, it includes contact information for customer service and manufacturer details.*
Figure 13 - b5387e98 figure 13
Figure 14 - b5387e98 figure 14
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
